FY23 · Released 29 May 2023
Underlying EBITDA up 32% but FY23 swung to a $2.1m NPAT loss on property items
A strong H1 masked a materially weaker second half, with implied H2 NPAT of -$3.8m against H1 NPAT of +$1.7m.
RAD · NZX
Radius Residential Care is an NZX-listed company covered by Annolyse across FY23. This page brings together the latest briefing, the current metrics snapshot, and the published history to date in one place.
Snapshot
FY23, released 29 May 2023
| Metric | Value |
|---|---|
| Revenue | $146.3m |
| NPAT | -$2.1m |
| DPS | 4929700.0c |
| Payout ratio vs NPAT % | 0.0% |
| Total assets | $356.6m |
Longitudinal view
Current-period values from each published briefing, with the most recent reporting period shown first.
| Metric | FY2312 MONTHS29 May 2023 |
|---|---|
| Revenue | $146.3m |
| Revenue growth % | 10.8% |
| NPAT | -$2.1m |
| DPS | 4929700.0c |
| Payout ratio vs NPAT % | 0.0% |
| Total assets | $356.6m |
Reference: annolyse.ai/companies/rad
Small multiples turn the table into a trend view while keeping the table above as the primary reference.
Reported revenue across covered periods.
Statutory profit after tax.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Accountability
Read the prior briefing's expectations and unresolved questions alongside the subsequent result, without forcing long-form editorial text into narrow cards.
Once a second briefing exists for this company, this section will compare the previous briefing's expectations and unresolved issues with what actually happened in the next result.
Archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
Email updates
Get future Annolyse briefings by email as soon as they are published.